Macrogenics Inc SEC filings MGNX
Macrogenics Inc has 944 filings in SEC EDGAR's recent list, going back to Nov 12, 2003. Its latest annual report, Form 10-K, was filed on Mar 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 3, 2026 | — |
| S-8 | Employee stock plan registration | Aug 14, 2025 | — |
| S-8 | Employee stock plan registration | May 23, 2024 | — |
| S-3 | Shelf registration | Nov 6, 2023 | — |
| S-8 | Employee stock plan registration | Jun 6, 2023 | — |
| POS AM | Filing | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 424B5 | Prospectus supplement | Apr 29, 2021 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| S-3ASR | Automatic shelf registration | Nov 4, 2020 | — |
| 424B5 | Prospectus supplement | Jun 19, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2020 | — |
| 424B5 | Prospectus supplement | Jan 3, 2020 | — |
| S-3 | Shelf registration | Dec 23, 2019 | — |
| S-8 | Employee stock plan registration | Mar 14, 2019 | — |
| 424B5 | Prospectus supplement | Feb 13, 2019 | — |
| 424B5 | Prospectus supplement | Feb 12, 2019 | — |
| 424B5 | Prospectus supplement | Mar 28, 2018 | — |
| 424B5 | Prospectus supplement | Mar 26, 2018 | — |
| S-8 | Employee stock plan registration | Mar 15, 2018 | — |
| 424B5 | Prospectus supplement | May 3, 2017 | — |
| S-8 | Employee stock plan registration | May 3, 2017 | — |
| 424B3 | Prospectus | Apr 27, 2017 | — |
| S-8 | Employee stock plan registration | Nov 2, 2016 | — |
| S-3ASR | Automatic shelf registration | Nov 2, 2016 | — |
| S-8 | Employee stock plan registration | Feb 29, 2016 | — |
| 424B5 | Prospectus supplement | Jul 15, 2015 | — |
| 424B5 | Prospectus supplement | Jul 13, 2015 | — |
| S-8 | Employee stock plan registration | Mar 3, 2015 | — |
| S-3 | Shelf registration | Nov 12, 2014 | — |
| 424B4 | Prospectus | Feb 13, 2014 | — |
| S-1MEF | Filing | Feb 12, 2014 | — |
| S-1/A | Amended registration statement | Feb 12, 2014 | — |
| S-1/A | Amended registration statement | Feb 10, 2014 | — |
| S-1 | Registration statement | Jan 30, 2014 | — |
| S-8 | Employee stock plan registration | Nov 12, 2013 | — |
| 424B4 | Prospectus | Oct 11, 2013 | — |
| S-1/A | Amended registration statement | Oct 9, 2013 | — |
| S-1/A | Amended registration statement | Oct 4, 2013 | — |
| S-1/A | Amended registration statement | Oct 1, 2013 | — |
| S-1/A | Amended registration statement | Sep 20, 2013 | — |
| S-1 | Registration statement | Sep 4, 2013 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MGNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1125345
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.